Alteration of GLIS3 gene expression pattern in patients with breast cancer

Background: The GLIS family members are zinc fingers with transcriptional repression and activation function. GLIS3 is one of these family members, which aberrant expression of it revealed to be related to several different cancer types. Regarding to the role of GLIS3 in tumor genesis and its probab...

Full description

Bibliographic Details
Main Authors: Farzaneh Rami, Azar Baradaran, Mahboobeh Mojaver Kahnamooi, Mansoor Salehi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2016;volume=5;issue=1;spage=44;epage=44;aulast=Rami
_version_ 1818309356082429952
author Farzaneh Rami
Azar Baradaran
Mahboobeh Mojaver Kahnamooi
Mansoor Salehi
author_facet Farzaneh Rami
Azar Baradaran
Mahboobeh Mojaver Kahnamooi
Mansoor Salehi
author_sort Farzaneh Rami
collection DOAJ
description Background: The GLIS family members are zinc fingers with transcriptional repression and activation function. GLIS3 is one of these family members, which aberrant expression of it revealed to be related to several different cancer types. Regarding to the role of GLIS3 in tumor genesis and its probable connection with β-catenin signaling pathway, one of the pathways that involves in both normal development and tumor genesis of breast tissue, the aim of this study is investigating the alteration of GLIS3 mRNA expression level in breast cancer. Materials and Methods: Real-time polymerase chain reaction performed with GLIS3 and GAPDH genes primer on the RNA which extracted from 15 fresh frozen breast tumor tissue samples and also 15 normal samples with slight distance from site of tumor. Results: The relative expression of GLIS3 in breast cancer tissues revealed a 4 times increase comparing normal breast tissues; with a significant difference between cancer and normal samples (P = 0.027) and in patients without lymph node involvement and tissues that had estrogen receptor (ER−) and progesterone receptor (PR−) statuses. We see no significant difference between cancer and normal tissues based on lobular or ductal origin of the tumor as well as the tumor grade. Conclusions: Our study suggested a probable relationship between GLIS3 overexpression and breast cancer. Furthermore, detection of a probable association between GLIS3 overexpression and triple-negative breast cancer (ER−/PR−/human epidermal growth factor receptor 2−) might be useful for prognostic and diagnostic uses or as a probable target for treatment of these patients.
first_indexed 2024-12-13T07:28:52Z
format Article
id doaj.art-f0703cb69945406884ad06c03f81435e
institution Directory Open Access Journal
issn 2277-9175
language English
last_indexed 2024-12-13T07:28:52Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-f0703cb69945406884ad06c03f81435e2022-12-21T23:55:16ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752016-01-0151444410.4103/2277-9175.178803Alteration of GLIS3 gene expression pattern in patients with breast cancerFarzaneh RamiAzar BaradaranMahboobeh Mojaver KahnamooiMansoor SalehiBackground: The GLIS family members are zinc fingers with transcriptional repression and activation function. GLIS3 is one of these family members, which aberrant expression of it revealed to be related to several different cancer types. Regarding to the role of GLIS3 in tumor genesis and its probable connection with β-catenin signaling pathway, one of the pathways that involves in both normal development and tumor genesis of breast tissue, the aim of this study is investigating the alteration of GLIS3 mRNA expression level in breast cancer. Materials and Methods: Real-time polymerase chain reaction performed with GLIS3 and GAPDH genes primer on the RNA which extracted from 15 fresh frozen breast tumor tissue samples and also 15 normal samples with slight distance from site of tumor. Results: The relative expression of GLIS3 in breast cancer tissues revealed a 4 times increase comparing normal breast tissues; with a significant difference between cancer and normal samples (P = 0.027) and in patients without lymph node involvement and tissues that had estrogen receptor (ER−) and progesterone receptor (PR−) statuses. We see no significant difference between cancer and normal tissues based on lobular or ductal origin of the tumor as well as the tumor grade. Conclusions: Our study suggested a probable relationship between GLIS3 overexpression and breast cancer. Furthermore, detection of a probable association between GLIS3 overexpression and triple-negative breast cancer (ER−/PR−/human epidermal growth factor receptor 2−) might be useful for prognostic and diagnostic uses or as a probable target for treatment of these patients.http://www.advbiores.net/article.asp?issn=2277-9175;year=2016;volume=5;issue=1;spage=44;epage=44;aulast=RamiBreast cancergene expressionGLIS3
spellingShingle Farzaneh Rami
Azar Baradaran
Mahboobeh Mojaver Kahnamooi
Mansoor Salehi
Alteration of GLIS3 gene expression pattern in patients with breast cancer
Advanced Biomedical Research
Breast cancer
gene expression
GLIS3
title Alteration of GLIS3 gene expression pattern in patients with breast cancer
title_full Alteration of GLIS3 gene expression pattern in patients with breast cancer
title_fullStr Alteration of GLIS3 gene expression pattern in patients with breast cancer
title_full_unstemmed Alteration of GLIS3 gene expression pattern in patients with breast cancer
title_short Alteration of GLIS3 gene expression pattern in patients with breast cancer
title_sort alteration of glis3 gene expression pattern in patients with breast cancer
topic Breast cancer
gene expression
GLIS3
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2016;volume=5;issue=1;spage=44;epage=44;aulast=Rami
work_keys_str_mv AT farzanehrami alterationofglis3geneexpressionpatterninpatientswithbreastcancer
AT azarbaradaran alterationofglis3geneexpressionpatterninpatientswithbreastcancer
AT mahboobehmojaverkahnamooi alterationofglis3geneexpressionpatterninpatientswithbreastcancer
AT mansoorsalehi alterationofglis3geneexpressionpatterninpatientswithbreastcancer